Publication Cover
Hemoglobin
international journal for hemoglobin research
Volume 48, 2024 - Issue 1
83
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Malaria Infection in Patients with Sickle Cell Disease in Nigeria: Association with Markers of Hyposplenism

, , , , , , , & show all
Pages 15-23 | Received 19 May 2023, Accepted 15 Nov 2023, Published online: 22 Jan 2024

References

  • Piel FB, Patil AP, Howes RE, et al. Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates. Lancet. 2013;381(9861):142–151. doi:10.1016/S0140-6736(12)61229-X.
  • Fleming AF. The presentation, management and prevention of crisis in sickle cell disease in Africa. Blood Rev. 1989;3(1):18–28. doi:10.1016/0268-960X(89)90022-2.
  • Cornille-Brøgger R, Fleming AF, Kagan I, et al. Abnormal haemoglobins in the Sudan savanna of Nigeria. II. Immunological response to malaria in normals and subjects with sickle cell trait. Ann Trop Med Parasitol. 1979;73(2):173–183. doi:10.1080/00034983.1979.11687244.
  • Serjeant GR. Mortality from sickle cell disease in Africa: interventions used to reduce mortality in non-malarial areas may be inappropriate. Br Med J. 2005;330(7489):432–433. doi:10.1136/bmj.330.7489.432.
  • Konotey-Ahulu F. Malaria and sickle-cell disease. Br Med J. 1971;2(5763):710–711. doi:10.1136/bmj.2.5763.710-d.
  • Gong L, Maiteki-Sebuguzi C, Rosenthal PJ, et al. Evidence for both innate and acquired mechanisms of protection from Plasmodium falciparum in children with sickle cell trait. Blood. 2012;119(16):3808–3814. doi:10.1182/blood-2011-08-371062.
  • Billo MA, Johnson ES, Doumbia SO, et al. Sickle cell trait protects against Plasmodium falciparum infection. Am J Epidemiol. 2012;176 Suppl 7 (Suppl. 7):S175–S185. doi:10.1093/aje/kws323.
  • Luzzatto L. Sickle cell anaemia and malaria. Mediterr J Hematol Infect Dis. 2012;4(1):1–6.
  • Cholera R, Brittain NJ, Gillrie MR, et al. Impaired cytoadherence of Plasmodium falciparum-infected erythrocytes containing sickle hemoglobin. Proc Natl Acad Sci USA. 2008;105(3):991–996. doi:10.1073/pnas.0711401105.
  • Albert NK, Julie  M, Manish  S, et al. Malaria  as a  cause of morbidity and mortality in  children  with  homozygous  sickle cell disease on the  coast of Kenya. Clin  Infect Dis. 2009;49(2):216. doi:10.1086/599834.
  • Aluoch J. Higher resistance to Plasmodium falciparum infection in patients with homozygous sickle cell disease in western Kenya. Trop Med Int Health. 1997;2(6):568–571. doi:10.1046/j.1365-3156.1997.d01-322.x.
  • McAuley CF, Webb C, Makani J, et al. High mortality from Plasmodium falciparum malaria in children living with sickle cell anemia on the coast of Kenya. Blood. 2010;116(10):1663–1668. doi:10.1182/blood-2010-01-265249.
  • Makani J, Komba AN, Cox SE, et al. Malaria in patients with sickle cell anemia: burden, risk factors, and outcome at the outpatient clinic and during hospitalization. Blood. 2010;115(2):215–220. doi:10.1182/blood-2009-07-233528.
  • Okuonghae H, Nwankwo M, Offor E. Malarial parasitaemia in febrile children with sickle cell anaemia. J Trop Pediatr. 1992;38(2):83–85. doi:10.1093/tropej/38.2.83.
  • Awotua-Efebo O, Alikor EAD, Nkanginieme KEO. Malaria parasite density and splenic status by ultrasonography in stable sickle-cell anaemia (HbSS) children. Niger J Med. 2004;13(1):40–43.
  • Aloni MN, Tshimanga BK, Ekulu PM, et al. Malaria, clinical features and acute crisis in children suffering from sickle cell disease in resource-limited settings: a retrospective description of 90 cases. Pathog Glob Health. 2013;107(4):198–201. doi:10.1179/2047773213Y.0000000089.
  • Ambe JP, Fatunde JO, Sodeinde OO. Associated morbidities in children with sickle-cell anaemia presenting with severe anaemia in a malarious area. Trop Doct. 2001;31(1):26–27. doi:10.1177/004947550103100109.
  • Akinyanju O, Johnson A. Acute illness in Nigerian children with sickle cell anaemia. Ann Trop Paediatr. 1987;7(3):181–186. doi:10.1080/02724936.1987.11748503.
  • Buffet PA, Safeukui I, Deplaine G, et al. The pathogenesis of Plasmodium falciparum malaria in humans: insights from splenic physiology. Blood. 2011;117(2):381–392. doi:10.1182/blood-2010-04-202911.
  • Chotivanich K, Udomsangpetch R, McGready R, et al. Central role of the spleen in malaria parasite clearance. J Infect Dis. 2002;185(10):1538–1541. doi:10.1086/340213.
  • Williams TN, Obaro SK. Sickle cell disease and malaria morbidity: a tale with two tails. Trends Parasitol. 2011;27(7):315–320. doi:10.1016/j.pt.2011.02.004.
  • Rogers ZR, Wang WC, Luo Z, et al. Biomarkers of splenic function in infants with sickle cell anemia: baseline data from the BABY HUG Trial. Blood. 2011;117(9):2614–2617. doi:10.1182/blood-2010-04-278747.
  • El Hoss S, Cochet S, Marin M, et al. Insights into determinants of spleen injury in sickle cell anemia. Blood Adv. 2019;3(15):2328–2336. doi:10.1182/bloodadvances.2019000106.
  • Adekile AD, Adeodu RO, Johnson W, et al. Pitted red cell counts in Nigerian children with sickle cell anaemia: correlation with age and splenic size. West Afr J Med. 1991;10(2):137–140.
  • Adekile AD, McKie KM, Adeodu OO, et al. Spleen in sickle cell anemia: comparative studies of Nigerian and U.S. patients. Am J Hematol. 1993;42(3):316–321. doi:10.1002/ajh.2830420313.
  • Ladu AI, Aiyenigba AO, Adekile A, et al. The spectrum of splenic complications in patients with sickle cell disease in Africa: a systematic review. Br J Haematol. 2021;193(1):26–42. doi:10.1111/bjh.17179.
  • Day KP, Marsh K. Naturally acquired immunity to Plasmodium falciparum. Parasitol Today. 1991;7(3):68–71. doi:10.1016/0169-4758(91)90037-O.
  • Snow R, De Azevedo IB, Lowe B, et al. Severe childhood malaria in two areas of markedly different falciparum transmission in east Africa. Acta Trop. 1994;57(4):289–300. doi:10.1016/0001-706x(94)90074-4.
  • Smith T, Felger I, Tanner M, et al. Premunition in Plasmodium falciparum infection: insights from the epidemiology of multiple infections. Trans R Soc Trop Med Hyg. 1999;93 Suppl 1 (Supplement_1):59–64. doi:10.1016/s0035-9203(99)90329-2.
  • Oyetunji IA, Amoo AJ, Adeyemo TA, et al. Asymptomatic malaria infection among children with sickle cell anaemia: the role of IL-10 and possible predisposing factors. PAMJ-One Health. 2020;2(7). doi:10.11604/pamj-oh.2020.2.7.22892.
  • Kotila R, Okesola A, Makanjuola O. Asymptomatic malaria parasitaemia in sickle-cell disease patients: how effective is chemoprophylaxis? J Vector Borne Dis. 2007;44(1):52–55.
  • Bell M, Card K. Maiduguri: city scoping study. Manchester: African Cities Research Consortium; 2021.
  • Waziri M. Spatial pattern of Maiduguri city. Researchers’ guide. Kano (Nigeria): Adamu Joji Publishers; 2012. p. 17–29.
  • Balogun ST, Sandabe UK, Okon KO, et al. Malaria burden and pre-hospital medication among subjects with malaria in Maiduguri, Northeast Nigeria. Heliyon. 2019;5(8):e02280. doi:10.1016/j.heliyon.2019.e02280.
  • Ayanugwo M, Kalu A. Variations in the prevalence of malaria in northern east Nigeria: studies on Maiduguri metropolis. Ann Borno. 1997;13(14):320.
  • Galadanci N, Wudil BJ, Balogun TM, et al. Current sickle cell disease management practices in Nigeria. Int Health. 2014;6(1):23–28. doi:10.1093/inthealth/iht022.
  • Ballas SK. More definitions in sickle cell disease: steady state v base line data. Am J Hematol. 2012;87(3):338–338. doi:10.1002/ajh.22259.
  • Ladu AI, Satumari NA, Abba AM, et al. Evaluation of two red cell inclusion staining methods for assessing spleen function among sickle cell disease patients in north-east Nigeria. PLOS Glob Public Health. 2023;3(5):e0001552. doi:10.1371/journal.pgph.0001552.
  • Ladu AI, Jeffery C, Farate A, et al. Determinants of splenic preservation among patients with sickle cell disease in north‐eastern Nigeria. Trop Med Int Health. 2023;28(8):620–628. doi:10.1111/tmi.13910.
  • Bain BJ, Bates I, Laffan MA. Dacie and Lewis practical haematology e-book. Elsevier Health Sciences; 2016.
  • Komba AN, Makani J, Sadarangani M, et al. Malaria as a cause of morbidity and mortality in children with homozygous sickle cell disease on the coast of Kenya. Clin Infect Dis. 2009;49(2):216–222. doi:10.1086/599834.
  • O'Meara WP, Barcus M, Wongsrichanalai C, et al. Reader technique as a source of variability in determining malaria parasite density by microscopy. Malar J. 2006;5(1):118. doi:10.1186/1475-2875-5-118.
  • Ladu AI, Jeffery C, Farate A, et al., editors. Ultrasonographic splenic indices among paediatric and adults with sickle cell disease in Nigeria. medRxiv. 2023.
  • Juwah A, Nlemadim A, Kaine W. Clinical presentation of severe anemia in pediatric patients with sickle cell anemia seen in Enugu, Nigeria. Am J Hematol. 2003;72(3):185–191. doi:10.1002/ajh.10285.
  • Ibidapo M, Akinyanju O. Acute sickle cell syndromes in Nigerian adults. Clin Lab Haematol. 2000;22(3):151–155. doi:10.1046/j.1365-2257.2000.00292.x.
  • Pasvol G, Weatherall D, Wilson R. Cellular mechanism for the protective effect of haemoglobin S against P. falciparum malaria. Nature. 1978;274(5672):701–703. doi:10.1038/274701a0.
  • Network TMGE. A global network for investigating the genomic epidemiology of malaria. Nature. 2008;456(7223):732.
  • Druilhe P, Perignon J. A hypothesis about the chronicity of malaria infection. Parasitol Today. 1997;13(9):353–357. doi:10.1016/s0169-4758(97)01095-8.
  • Safeukui I, Correas JM, Brousse V, et al. Retention of Plasmodium falciparum ring-infected erythrocytes in the slow, open microcirculation of the human spleen. Blood. 2008;112(6):2520–2528. doi:10.1182/blood-2008-03-146779.
  • Bach O, Baier M, Pullwitt A, et al. Falciparum malaria after splenectomy: a prospective controlled study of 33 previously splenectomized Malawian adults. Trans R Soc Trop Med Hyg. 2005;99(11):861–867. doi:10.1016/j.trstmh.2005.03.008.
  • Boone KE, Watters DA. The incidence of malaria after splenectomy in Papua New Guinea. BMJ. 1995;311(7015):1273–1273. doi:10.1136/bmj.311.7015.1273.
  • Awodu OA, Wagbatsoma VA, Enosolease ME. Malaria parasitemia and antimalaria prophylaxis in sickle cell anemia patients in steady state. Orak hücreli anemi hastalarιnda malarya parazitemisi ve anti-malarya profilaksisi. Turk J Haematol. 2008;25(1):8–12.
  • Oniyangi O, Omari AA. Malaria chemoprophylaxis in sickle cell disease. Cochrane Database Syst Rev. 2006;2019(11). doi:10.1002/14651858.CD003489.pub2.
  • Aneni EC, Hamer DH, Gill CJ. Systematic review of current and emerging strategies for reducing morbidity from malaria in sickle cell disease. Trop Med Int Health. 2013;18(3):313–327. doi:10.1111/tmi.12056.
  • Opoka R, Ndugwa C, Latham TS, et al. Novel use of hydroxyurea in an African region with malaria (NOHARM): a randomized controlled trial. Blood. 2017;130(Suppl_1):759–759. doi:10.1182/blood.V130.Suppl_1.759.759.
  • Bowers KM, Bell D, Chiodini PL, et al. Inter-rater reliability of malaria parasite counts and comparison of methods. Malar J. 2009;8(1):267. doi:10.1186/1475-2875-8-267.
  • Planche T, Krishna S, Kombila M, et al. Comparison of methods for the rapid laboratory assessment of children with malaria. Am J Trop Med Hyg. 2001;65(5):599–602. doi:10.4269/ajtmh.2001.65.599.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.